Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,405 | -4,356 | -2,301 | -17,504 | -14,238 |
| Depreciation Amortization | 285 | 195 | 25 | 446 | 345 |
| Other Working Capital | -327 | -951 | -672 | 140 | 152 |
| Other Operating Activity | -9 | 18 | 9 | 433 | 416 |
| Operating Cash Flow | $-6,456 | $-5,094 | $-2,939 | $-16,485 | $-13,325 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | N/A | N/A | -8 | -8 |
| Investing Cash Flow | $-12 | $N/A | $N/A | $-8 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,337 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $4,337 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 9,935 | 9,935 | 9,935 | 26,428 | 26,428 |
| End Cash Position | 7,804 | 4,841 | 6,996 | 9,935 | 13,095 |
| Net Cash Flow | $-2,131 | $-5,094 | $-2,939 | $-16,493 | $-13,333 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,456 | -5,094 | -2,939 | -16,485 | -13,325 |
| Capital Expenditure | -12 | N/A | N/A | -8 | -8 |
| Free Cash Flow | -6,468 | -5,094 | -2,939 | -16,493 | -13,333 |